TEVA
Teva Pharmaceutical·NYSE
--
--(--)
--
--(--)
TEVA Filings
Filing Date
Form Description
Form Type
2026-02-03
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Financials
2026-02-03 · Financials
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026-01-29
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-01-29 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-01-29
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-01-29 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-01-29
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-01-29 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-01-29
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-01-29 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-01-29
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-01-29 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-01-28
Teva Pharmaceutical Industries Limited (TEVA) Q4 2025 Earnings Call Transcript
Earnings Call
2026-01-28 · Earnings Call
Teva Pharmaceutical Industries Limited (TEVA) Q4 2025 Earnings Call Transcript
2026-01-28
Form 8-K - Current report
Key Events
2026-01-28 · Key Events
Form 8-K - Current report
2026-01-12
Form 8-K - Current report
Key Events
2026-01-12 · Key Events
Form 8-K - Current report
2025-12-18
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-18 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
